News

The story behind the development of immune checkpoint inhibitors, fulfilling the promise of cancer immunotherapy ...
This article is part of Harvard Medical School’s continuing coverage of medicine, biomedical research, medical education and policy related to the SARS-CoV-2 pandemic and the disease COVID-19.
At a glance: Immunotherapy has redefined cancer treatment, but not all patients experience the same benefit when treated. New research in mice identifies how gut bacteria alter the body’s response to ...
Dolores J. Brown Staff Award This award, presented by the HMS Office of Human Resources, was established in 2002 by the Brown family to honor Dolores J. Brown and commemorate her contributions to the ...
Ashwini Jambhekar , PhDTeaching Associate in Science Communication ...
Crystal Chang, MPHAssociate Director of Education, Master of Science in Bioethics ...
Christina Lively, MEdAssociate Director of Education Programs ...
But this evolution toward the free market has pros and cons for doctors and patients alike, highlighting an urgency to ...
Separate from the criminal investigation into Cedric Lodge’s activities and as part of its oversight of Harvard Medical School, the Harvard University Office of the President and Provost appointed a ...
The female genital tract is naturally colonized by mixed communities of bacteria, known as the vaginal microbiome. When these communities are dominated by species such as Lactobacillus crispatus, the ...
When Vijay Sankaran was an MD-PhD student at Harvard Medical School in the mid-2000s, one of his first clinical encounters was with a 24-year-old patient whose sickle cell disease left them with ...